Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
Twist Bioscience (NASDAQ: TWST), a synthetic DNA manufacturer, announced its participation in the 7th Annual Evercore HealthCONx Conference. CEO and co-founder Emily M. Leproust, Ph.D., along with CFO Adam Laponis, will engage in a fireside chat on December 3, 2024, at 10:00 a.m. Eastern Time in Coral Gables, Florida. The event will be accessible via live webcast through the company's investor relations website, with a replay available for 30 days after the presentation.
Twist Bioscience (NASDAQ: TWST), un produttore di DNA sintetico, ha annunciato la sua partecipazione alla 7ª Conferenza Annuale Evercore HealthCONx. L'amministratore delegato e co-fondatore Emily M. Leproust, Ph.D., insieme al CFO Adam Laponis, parteciperanno a una chiacchierata informale il 3 dicembre 2024, alle 10:00 ora orientale a Coral Gables, Florida. L'evento sarà accessibile tramite webcast dal vivo attraverso il sito web delle relazioni con gli investitori dell'azienda, con una riproduzione disponibile per 30 giorni dopo la presentazione.
Twist Bioscience (NASDAQ: TWST), un fabricante de ADN sintético, anunció su participación en la 7ª Conferencia Anual Evercore HealthCONx. La CEO y cofundadora Emily M. Leproust, Ph.D., junto con el CFO Adam Laponis, participarán en una charla informal el 3 de diciembre de 2024, a las 10:00 a.m. hora del Este en Coral Gables, Florida. El evento será accesible a través de una transmisión en vivo a través del sitio web de relaciones con inversores de la empresa, con una repetición disponible durante 30 días después de la presentación.
트위스트 바이오사이언스 (NASDAQ: TWST), 합성 DNA 제조업체,가 제7회 에버코어 헬스CONx 콘퍼런스에 참여한다고 발표했습니다. CEO이자 공동 설립자인 에밀리 M. 레프루스트 박사와 CFO 아담 라포니스는 2024년 12월 3일 오전 10시 동부 표준시 플로리다주 코랄 게이블스에서 열린 대담에 참여할 예정입니다. 이번 행사는 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 접근할 수 있으며, 발표 후 30일 동안 다시 볼 수 있습니다.
Twist Bioscience (NASDAQ: TWST), un fabricant d'ADN synthétique, a annoncé sa participation à la 7ème Conférence Annuelle Evercore HealthCONx. La PDG et cofondatrice Emily M. Leproust, Ph.D., ainsi que le CFO Adam Laponis, participeront à une discussion conviviale le 3 décembre 2024 à 10h00 heure de l'Est à Coral Gables, en Floride. L'événement sera accessible via un webinaire en direct sur le site Web des relations avec les investisseurs de l'entreprise, avec une rediffusion disponible pendant 30 jours après la présentation.
Twist Bioscience (NASDAQ: TWST), ein Hersteller von synthetischer DNA, hat seine Teilnahme an der 7. Jahreskonferenz Evercore HealthCONx bekannt gegeben. CEO und Mitgründerin Emily M. Leproust, Ph.D., wird zusammen mit CFO Adam Laponis am 3. Dezember 2024 um 10:00 Uhr Eastern Time in Coral Gables, Florida, an einem informellen Gespräch teilnehmen. Die Veranstaltung wird über ein Live-Webcast auf der Website für Investorenbeziehungen des Unternehmens zugänglich sein, mit einer Wiederholung, die 30 Tage nach der Präsentation verfügbar ist.
- None.
- None.
The fireside chat will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20241114463991/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When will Twist Bioscience (TWST) present at the Evercore HealthCONx Conference 2024?
How can I watch Twist Bioscience's (TWST) presentation at the 2024 Evercore Conference?
Who will represent Twist Bioscience (TWST) at the 2024 Evercore HealthCONx Conference?
